EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Troriluzole attenuates opioid intake, reinforcing efficacy, seeking behaviours, physical dependence and antinociceptive tolerance in rats

Ewa Galaj, Saadet Inan, Guo-Hua Bi, Sonita Wiah, George Adamson, Allen B Reitz, Zheng-Xiong Xi iD, Scott M Rawls

British Journal of Pharmacology · 2026

DOI: 10.1111/bph.70206 ↗

At a glance

Journal article in British Journal of Pharmacology, 2026. Written by Ewa Galaj and 7 co-authors. Institution: Psychological and Brain Sciences, Colgate University, Hamilton, New York, USA. Major MEDLINE topics: Analgesics, Opioid, Opioid-Related Disorders, Drug-Seeking Behavior. Cited 2 times so far (Crossref); 72 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIDA NIH HHS, Intramural Research Program, NIH HHS.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background and Purpose Riluzole, approved for amyotrophic lateral sclerosis (ALS), has a glutamate‐modulating profile favourable for mitigating opioid addiction. It reduces neuronal glutamate release and enhances glutamate reuptake, offering advantages over agents that only increase glutamate reuptake. However, riluzole has pharmacokinetic liabilities that limit repurposing. To overcome these limitations, we designed and prepared the prodrug troriluzole (TRLZ), which retains the mechanistic profile of riluzole but with optimized metabolic and pharmacokinetic properties (e.g., higher oral bioavailability and less pharmacokinetic variability). As dysregulation of glutamate systems during opioid exposure contributes to adverse opioid effects, we tested the hypothesis that TRLZ would inhibit several opioid‐derived adverse effects in rats. Experimental Approach In male Long–Evans and Sprague–Dawley rats, effects of TRLZ on oxycodone self‐administration were investigated under fixed‐ratio and progressive‐ratio reinforcement schedules. Effects of TRLZ on food self‐administration were also investigated. TRLZ effects on cue‐induced reinstatement of oxycodone seeking, and on morphine‐induced physical dependence, antinociceptive tolerance and respiratory depression were also investigated. TRLZ was administered intraperitoneally. Key Results TRLZ dose‐dependently reduced oxycodone self‐administration, reinforcing efficacy and cue‐induced reinstatement of oxycodone seeking without affecting inactive lever responding. TRLZ, at high doses, also inhibited food self‐administration. TRLZ reduced naloxone‐precipitated withdrawal signs in morphine‐dependent rats and antinociceptive tolerance during repeated morphine exposure. TRLZ also attenuated morphine‐induced respiratory depression. Conclusions and Implications TRLZ, already in clinical trials for cerebellar ataxia, also reduced opioid taking and seeking as well as opioid‐derived adverse effects in rats, supporting further study in treating opioid use disorders and pain management.

Subjects

MeSH terms (MEDLINE)

Analgesics, OpioidOpioid-Related DisordersDrug-Seeking BehaviorAnimalsMaleRats, Sprague-DawleyDrug ToleranceRatsRats, Long-EvansSelf AdministrationOxycodoneMorphineBehavior, AnimalReinforcement, PsychologyRiluzole

Author keywords

GLT‐1glutamatemorphineopioidoxycodonerelapsetolerancetroriluzole

Substances

Analgesics, OpioidOxycodoneMorphineRiluzole

Authors and institutions

  • Psychological and Brain Sciences, Colgate University, Hamilton, New York, USA.
  • Addiction Biology Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, Maryland, USA.
  • Center for Substance Abuse Research, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, USA.
  • Fox Chase Therapeutics Discovery Incorporated, Doylestown, Pennsylvania, USA.
  • Department of Neural Sciences, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, USA.

ORCID profiles: Zheng-Xiong Xi

Funding

  • NIDA NIH HHS
  • Intramural Research Program
  • NIH HHS
  • Intramural NIH HHS
  • NIAAA NIH HHS

Cite

APA

Galaj, E., Inan, S., Bi, G. H., Wiah, S., Adamson, G., Reitz, A. B., Xi, Z. X., & Rawls, S. M. (2026). Troriluzole attenuates opioid intake, reinforcing efficacy, seeking behaviours, physical dependence and antinociceptive tolerance in rats. British Journal of Pharmacology. https://doi.org/10.1111/bph.70206

Vancouver

Galaj E, Inan S, Bi GH, Wiah S, Adamson G, Reitz AB, et al. Troriluzole attenuates opioid intake, reinforcing efficacy, seeking behaviours, physical dependence and antinociceptive tolerance in rats. British Journal of Pharmacology. 2026. doi:10.1111/bph.70206

BibTeX
@article{Galaj2026,
  author = {Galaj, Ewa and Inan, Saadet and Bi, Guo-Hua and Wiah, Sonita and Adamson, George and Reitz, Allen B and Xi, Zheng-Xiong and Rawls, Scott M},
  title = {Troriluzole attenuates opioid intake, reinforcing efficacy, seeking behaviours, physical dependence and antinociceptive tolerance in rats},
  journal = {British Journal of Pharmacology},
  year = {2026},
  doi = {10.1111/bph.70206}
}
Start for free →